Caffeine Completed Phase 4 Trials for Cardiovascular Disease (CVD) / Ischemia-Reperfusion Injury Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00430170Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?